Click for best price
Gene Therapy Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Gene Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Drugs. This report contains market size and forecasts of Gene Therapy Drugs in global, including the following market information:
Global Gene Therapy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Neuromuscular Disease Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy Drugs include F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical?Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy Drugs Market Segment Percentages, by Type, 2022 (%)
- Neuromuscular Disease
- Genetic Disease
- Other
Global Gene Therapy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy Drugs Market Segment Percentages, by Application, 2022 (%)
Global Gene Therapy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Therapy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-La Roche AG
- Novartis International AG
- Gilead Sciences, Inc.
- Ultragenyx Pharmaceutical?Inc.
- Applied Genetic Technologies Corp
- Audentes Therapeutics
- BioMarin Pharmaceutical
- Bluebird Bio
- Nightstar Therapeutics
- Sangamo Therapeutics
- Spark Therapeutics
- uniQure
- VBL Therapeutics
- Voyager Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy Drugs, market overview.
Chapter 2: Global Gene Therapy Drugs market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gene Therapy Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Drugs Overall Market Size
2.1 Global Gene Therapy Drugs Market Size: 2022 VS 2029
2.2 Global Gene Therapy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy Drugs Players in Global Market
3.2 Top Global Gene Therapy Drugs Companies Ranked by Revenue
3.3 Global Gene Therapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy Drugs Market Size Markets, 2022 & 2029
4.1.2 Neuromuscular Disease
4.1.3 Genetic Disease
4.1.4 Other
4.2 By Type - Global Gene Therapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy Drugs Revenue, 2024-2029
4.2.3 By Type - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Gene Therapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy Drugs Revenue, 2024-2029
5.2.3 By Application - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Therapy Drugs Market Size, 2022 & 2029
6.2 By Region - Global Gene Therapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy Drugs Revenue, 2024-2029
6.2.3 By Region - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Therapy Drugs Revenue, 2018-2029
6.3.2 US Gene Therapy Drugs Market Size, 2018-2029
6.3.3 Canada Gene Therapy Drugs Market Size, 2018-2029
6.3.4 Mexico Gene Therapy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Therapy Drugs Revenue, 2018-2029
6.4.2 Germany Gene Therapy Drugs Market Size, 2018-2029
6.4.3 France Gene Therapy Drugs Market Size, 2018-2029
6.4.4 U.K. Gene Therapy Drugs Market Size, 2018-2029
6.4.5 Italy Gene Therapy Drugs Market Size, 2018-2029
6.4.6 Russia Gene Therapy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Gene Therapy Drugs Market Size, 2018-2029
6.4.8 Benelux Gene Therapy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Therapy Drugs Revenue, 2018-2029
6.5.2 China Gene Therapy Drugs Market Size, 2018-2029
6.5.3 Japan Gene Therapy Drugs Market Size, 2018-2029
6.5.4 South Korea Gene Therapy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Gene Therapy Drugs Market Size, 2018-2029
6.5.6 India Gene Therapy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Therapy Drugs Revenue, 2018-2029
6.6.2 Brazil Gene Therapy Drugs Market Size, 2018-2029
6.6.3 Argentina Gene Therapy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy Drugs Revenue, 2018-2029
6.7.2 Turkey Gene Therapy Drugs Market Size, 2018-2029
6.7.3 Israel Gene Therapy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Therapy Drugs Market Size, 2018-2029
6.7.5 UAE Gene Therapy Drugs Market Size, 2018-2029
7 Gene Therapy Drugs Companies Profiles
7.1 F. Hoffmann-La Roche AG
7.1.1 F. Hoffmann-La Roche AG Company Summary
7.1.2 F. Hoffmann-La Roche AG Business Overview
7.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Major Product Offerings
7.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.2 Novartis International AG
7.2.1 Novartis International AG Company Summary
7.2.2 Novartis International AG Business Overview
7.2.3 Novartis International AG Gene Therapy Drugs Major Product Offerings
7.2.4 Novartis International AG Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis International AG Key News & Latest Developments
7.3 Gilead Sciences, Inc.
7.3.1 Gilead Sciences, Inc. Company Summary
7.3.2 Gilead Sciences, Inc. Business Overview
7.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Major Product Offerings
7.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences, Inc. Key News & Latest Developments
7.4 Ultragenyx Pharmaceutical?Inc.
7.4.1 Ultragenyx Pharmaceutical?Inc. Company Summary
7.4.2 Ultragenyx Pharmaceutical?Inc. Business Overview
7.4.3 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Major Product Offerings
7.4.4 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.4.5 Ultragenyx Pharmaceutical?Inc. Key News & Latest Developments
7.5 Applied Genetic Technologies Corp
7.5.1 Applied Genetic Technologies Corp Company Summary
7.5.2 Applied Genetic Technologies Corp Business Overview
7.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Major Product Offerings
7.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.5.5 Applied Genetic Technologies Corp Key News & Latest Developments
7.6 Audentes Therapeutics
7.6.1 Audentes Therapeutics Company Summary
7.6.2 Audentes Therapeutics Business Overview
7.6.3 Audentes Therapeutics Gene Therapy Drugs Major Product Offerings
7.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.6.5 Audentes Therapeutics Key News & Latest Developments
7.7 BioMarin Pharmaceutical
7.7.1 BioMarin Pharmaceutical Company Summary
7.7.2 BioMarin Pharmaceutical Business Overview
7.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Major Product Offerings
7.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.7.5 BioMarin Pharmaceutical Key News & Latest Developments
7.8 Bluebird Bio
7.8.1 Bluebird Bio Company Summary
7.8.2 Bluebird Bio Business Overview
7.8.3 Bluebird Bio Gene Therapy Drugs Major Product Offerings
7.8.4 Bluebird Bio Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.8.5 Bluebird Bio Key News & Latest Developments
7.9 Nightstar Therapeutics
7.9.1 Nightstar Therapeutics Company Summary
7.9.2 Nightstar Therapeutics Business Overview
7.9.3 Nightstar Therapeutics Gene Therapy Drugs Major Product Offerings
7.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.9.5 Nightstar Therapeutics Key News & Latest Developments
7.10 Sangamo Therapeutics
7.10.1 Sangamo Therapeutics Company Summary
7.10.2 Sangamo Therapeutics Business Overview
7.10.3 Sangamo Therapeutics Gene Therapy Drugs Major Product Offerings
7.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.10.5 Sangamo Therapeutics Key News & Latest Developments
7.11 Spark Therapeutics
7.11.1 Spark Therapeutics Company Summary
7.11.2 Spark Therapeutics Business Overview
7.11.3 Spark Therapeutics Gene Therapy Drugs Major Product Offerings
7.11.4 Spark Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.11.5 Spark Therapeutics Key News & Latest Developments
7.12 uniQure
7.12.1 uniQure Company Summary
7.12.2 uniQure Business Overview
7.12.3 uniQure Gene Therapy Drugs Major Product Offerings
7.12.4 uniQure Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.12.5 uniQure Key News & Latest Developments
7.13 VBL Therapeutics
7.13.1 VBL Therapeutics Company Summary
7.13.2 VBL Therapeutics Business Overview
7.13.3 VBL Therapeutics Gene Therapy Drugs Major Product Offerings
7.13.4 VBL Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.13.5 VBL Therapeutics Key News & Latest Developments
7.14 Voyager Therapeutics
7.14.1 Voyager Therapeutics Company Summary
7.14.2 Voyager Therapeutics Business Overview
7.14.3 Voyager Therapeutics Gene Therapy Drugs Major Product Offerings
7.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.14.5 Voyager Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Therapy Drugs Market Opportunities & Trends in Global Market
Table 2. Gene Therapy Drugs Market Drivers in Global Market
Table 3. Gene Therapy Drugs Market Restraints in Global Market
Table 4. Key Players of Gene Therapy Drugs in Global Market
Table 5. Top Gene Therapy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapy Drugs Product Type
Table 9. List of Global Tier 1 Gene Therapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Therapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene Therapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Therapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene Therapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Therapy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapy Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapy Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapy Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapy Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapy Drugs Revenue, (US$, Mn), 2024-2029
Table 30. F. Hoffmann-La Roche AG Company Summary
Table 31. F. Hoffmann-La Roche AG Gene Therapy Drugs Product Offerings
Table 32. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. F. Hoffmann-La Roche AG Key News & Latest Developments
Table 34. Novartis International AG Company Summary
Table 35. Novartis International AG Gene Therapy Drugs Product Offerings
Table 36. Novartis International AG Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis International AG Key News & Latest Developments
Table 38. Gilead Sciences, Inc. Company Summary
Table 39. Gilead Sciences, Inc. Gene Therapy Drugs Product Offerings
Table 40. Gilead Sciences, Inc. Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Gilead Sciences, Inc. Key News & Latest Developments
Table 42. Ultragenyx Pharmaceutical?Inc. Company Summary
Table 43. Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Product Offerings
Table 44. Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Ultragenyx Pharmaceutical?Inc. Key News & Latest Developments
Table 46. Applied Genetic Technologies Corp Company Summary
Table 47. Applied Genetic Technologies Corp Gene Therapy Drugs Product Offerings
Table 48. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Applied Genetic Technologies Corp Key News & Latest Developments
Table 50. Audentes Therapeutics Company Summary
Table 51. Audentes Therapeutics Gene Therapy Drugs Product Offerings
Table 52. Audentes Therapeutics Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Audentes Therapeutics Key News & Latest Developments
Table 54. BioMarin Pharmaceutical Company Summary
Table 55. BioMarin Pharmaceutical Gene Therapy Drugs Product Offerings
Table 56. BioMarin Pharmaceutical Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. BioMarin Pharmaceutical Key News & Latest Developments
Table 58. Bluebird Bio Company Summary
Table 59. Bluebird Bio Gene Therapy Drugs Product Offerings
Table 60. Bluebird Bio Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bluebird Bio Key News & Latest Developments
Table 62. Nightstar Therapeutics Company Summary
Table 63. Nightstar Therapeutics Gene Therapy Drugs Product Offerings
Table 64. Nightstar Therapeutics Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Nightstar Therapeutics Key News & Latest Developments
Table 66. Sangamo Therapeutics Company Summary
Table 67. Sangamo Therapeutics Gene Therapy Drugs Product Offerings
Table 68. Sangamo Therapeutics Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Sangamo Therapeutics Key News & Latest Developments
Table 70. Spark Therapeutics Company Summary
Table 71. Spark Therapeutics Gene Therapy Drugs Product Offerings
Table 72. Spark Therapeutics Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Spark Therapeutics Key News & Latest Developments
Table 74. uniQure Company Summary
Table 75. uniQure Gene Therapy Drugs Product Offerings
Table 76. uniQure Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. uniQure Key News & Latest Developments
Table 78. VBL Therapeutics Company Summary
Table 79. VBL Therapeutics Gene Therapy Drugs Product Offerings
Table 80. VBL Therapeutics Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. VBL Therapeutics Key News & Latest Developments
Table 82. Voyager Therapeutics Company Summary
Table 83. Voyager Therapeutics Gene Therapy Drugs Product Offerings
Table 84. Voyager Therapeutics Gene Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Voyager Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Gene Therapy Drugs Segment by Type in 2022
Figure 2. Gene Therapy Drugs Segment by Application in 2022
Figure 3. Global Gene Therapy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Therapy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2022
Figure 8. By Type - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Therapy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Therapy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 16. US Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 28. China Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Therapy Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Therapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis International AG Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Gilead Sciences, Inc. Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Audentes Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BioMarin Pharmaceutical Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bluebird Bio Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nightstar Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sangamo Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Spark Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. uniQure Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. VBL Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Voyager Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
